Yang, Jianxin

Qwen3 Technical Report

Yang, A., Li, A., Yang, B., Zhang, B., Hui, B., Zheng, B., Yu, B., Gao, C., Huang, C., Lv, C., et al. (2025) · arXiv

Topic ModelingNatural Language Processing Techniques

Cited by 17,283

Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor

Gonzales, A. J., Hook, K. E., Althaus, I. W., Ellis, P. A., Trachet, E., Delaney, A. M., Harvey, P. J., Ellis, T. A., Amato, D. M., Nelson, J. M., et al. (2008) · Molecular Cancer Therapeutics

HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations

Cited by 226

Qwen2.5 Technical Report

Qwen, :, Yang, A., Yang, B., Zhang, B., Hui, B., Zheng, B., Yu, B., Li, C., Liu, D., et al. (2024) · arXiv

Topic ModelingNatural Language Processing Techniques

Cited by 128

Qwen2 Technical Report

Yang, A., Yang, B., Hui, B., Zheng, B., Yu, B., Zhou, C., Li, C., Li, C., Liu, D., Huang, F., et al. (2024) · arXiv

Topic ModelingNatural Language Processing Techniques

Cited by 63

Qwen3-Omni Technical Report

Xu, J., Guo, Z., Hu, H., Chu, Y., Wang, X., He, J., Wang, Y., Shi, X., He, T., Zhu, X., et al. (2025) · arXiv

Multimodal Machine Learning ApplicationsSpeech Recognition and Synthesis

Cited by 2